Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Apr 2, 2019 · 10-K · 92 days after period end · 0001144204-19-017803
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 |
|---|---|---|---|---|
| Revenue | — | $32.00K | $71.00K | $863.00K |
| Net Income | -$5.65M | -$27.00M | -$30.71M | -$24.08M |
| EPS Diluted | — | — |
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
| — |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2018 · filed Apr 2, 2019 · 92 d after period end
